Clinical Trials Directory

Trials / Completed

CompletedNCT00335257

International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)

International Active Surveillance Study of Women Taking Oral Contraceptives (INAS OC)

Status
Completed
Phase
Study type
Observational
Enrollment
85,109 (actual)
Sponsor
Center for Epidemiology and Health Research, Germany · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The study compares the short- and long-term risks of a 24-day regimen of a drospirenone-containing oral contraceptive with the risks of established oral contraceptives in a study population that is representative for the actual users of the individual preparations.

Detailed description

Drospirenone is a novel progestogen with antiandrogenic and antimineralocorticoid properties. A large active post-marketing surveillance study has demonstrated that a 21-day regimen of 3mg drospirenone and 30mcg ethinylestradiol can be used safely for oral contraception. This study investigates the risks of short and long-term use of a 24-day regimen of drospirenone/ethinylestradiol in comparison to established OCs in a study population that is representative of the actual users of the individual preparations. INAS-OC is a prospective, controlled, non-interventional cohort study with two study arms: OCs containing drospirenone and OCs containing any other progestogen. The study was started in the USA in April 2005 and was extended to several European countries in September 2008 based on the launch status of the 24-day regimen. New users of an OC (starters, switchers without a pill intake break and recurrent users with a pill intake break \[same or different OC\]) are accrued by a network of prescribing physicians. Baseline and follow-up information are collected via a self-administered questionnaire. Data analysis will be based on life-table methods comparing the cohorts. All analyses will make allowance for confounding, using methods that will include multivariate techniques such as Cox regression.

Conditions

Timeline

Start date
2005-08-01
Primary completion
2013-01-01
Completion
2013-03-01
First posted
2006-06-09
Last updated
2019-08-07
Results posted
2014-11-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00335257. Inclusion in this directory is not an endorsement.